nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—CYP2E1—prostate cancer	0.111	0.382	CbGaD
Zafirlukast—CYP2C19—prostate cancer	0.11	0.378	CbGaD
Zafirlukast—CYP3A4—prostate cancer	0.0701	0.24	CbGaD
Zafirlukast—ABCG2—Cabazitaxel—prostate cancer	0.0235	0.0499	CbGbCtD
Zafirlukast—ABCG2—Estrone—prostate cancer	0.0229	0.0488	CbGbCtD
Zafirlukast—CYP2C8—Nilutamide—prostate cancer	0.0204	0.0434	CbGbCtD
Zafirlukast—CYP2C19—Bicalutamide—prostate cancer	0.0171	0.0364	CbGbCtD
Zafirlukast—CYP2C19—Nilutamide—prostate cancer	0.0171	0.0364	CbGbCtD
Zafirlukast—CYP2C8—Abiraterone—prostate cancer	0.0169	0.0359	CbGbCtD
Zafirlukast—CYP2E1—Estrone—prostate cancer	0.0164	0.0348	CbGbCtD
Zafirlukast—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0157	0.0335	CbGbCtD
Zafirlukast—ABCG2—Conjugated Estrogens—prostate cancer	0.015	0.0319	CbGbCtD
Zafirlukast—CYP2C9—Bicalutamide—prostate cancer	0.0142	0.0302	CbGbCtD
Zafirlukast—CYP2C9—Nilutamide—prostate cancer	0.0142	0.0302	CbGbCtD
Zafirlukast—CYP2C19—Flutamide—prostate cancer	0.0142	0.0301	CbGbCtD
Zafirlukast—ABCG2—Mitoxantrone—prostate cancer	0.0136	0.029	CbGbCtD
Zafirlukast—ABCG2—Estradiol—prostate cancer	0.0132	0.028	CbGbCtD
Zafirlukast—CYP1A2—Flutamide—prostate cancer	0.0131	0.0278	CbGbCtD
Zafirlukast—CYP2D6—Bicalutamide—prostate cancer	0.013	0.0277	CbGbCtD
Zafirlukast—CYP2C8—Cabazitaxel—prostate cancer	0.0125	0.0266	CbGbCtD
Zafirlukast—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0109	0.0232	CbGbCtD
Zafirlukast—CYP2D6—Abiraterone—prostate cancer	0.0108	0.0229	CbGbCtD
Zafirlukast—CYP2E1—Mitoxantrone—prostate cancer	0.00973	0.0207	CbGbCtD
Zafirlukast—CYP1A2—Estrone—prostate cancer	0.00946	0.0201	CbGbCtD
Zafirlukast—ABCG2—Etoposide—prostate cancer	0.0086	0.0183	CbGbCtD
Zafirlukast—CYP2C9—Estrone—prostate cancer	0.00852	0.0181	CbGbCtD
Zafirlukast—CYP3A4—Bicalutamide—prostate cancer	0.00827	0.0176	CbGbCtD
Zafirlukast—PTGS1—Etoposide—prostate cancer	0.00794	0.0169	CbGbCtD
Zafirlukast—ABCG2—Docetaxel—prostate cancer	0.00787	0.0167	CbGbCtD
Zafirlukast—CYP3A4—Estramustine—prostate cancer	0.00769	0.0164	CbGbCtD
Zafirlukast—CYP2C8—Estradiol—prostate cancer	0.00702	0.0149	CbGbCtD
Zafirlukast—CYP3A4—Abiraterone—prostate cancer	0.00685	0.0146	CbGbCtD
Zafirlukast—CYP3A4—Flutamide—prostate cancer	0.00685	0.0146	CbGbCtD
Zafirlukast—CYP2C9—Capecitabine—prostate cancer	0.00646	0.0137	CbGbCtD
Zafirlukast—CYP1A2—Conjugated Estrogens—prostate cancer	0.00619	0.0132	CbGbCtD
Zafirlukast—CYP2E1—Etoposide—prostate cancer	0.00613	0.013	CbGbCtD
Zafirlukast—CYP2C19—Estradiol—prostate cancer	0.00589	0.0125	CbGbCtD
Zafirlukast—ABCG2—Doxorubicin—prostate cancer	0.00587	0.0125	CbGbCtD
Zafirlukast—CYP1A2—Estradiol—prostate cancer	0.00543	0.0116	CbGbCtD
Zafirlukast—CYP3A4—Cabazitaxel—prostate cancer	0.00507	0.0108	CbGbCtD
Zafirlukast—CYP2C19—Prednisone—prostate cancer	0.00506	0.0108	CbGbCtD
Zafirlukast—CYP3A4—Estrone—prostate cancer	0.00496	0.0105	CbGbCtD
Zafirlukast—CYP2C9—Estradiol—prostate cancer	0.0049	0.0104	CbGbCtD
Zafirlukast—CYP2C8—Etoposide—prostate cancer	0.00458	0.00974	CbGbCtD
Zafirlukast—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00442	0.00939	CbGbCtD
Zafirlukast—CYP1A2—Etoposide—prostate cancer	0.00355	0.00754	CbGbCtD
Zafirlukast—CYP3A4—Conjugated Estrogens—prostate cancer	0.00324	0.00689	CbGbCtD
Zafirlukast—CYP3A4—Mitoxantrone—prostate cancer	0.00295	0.00627	CbGbCtD
Zafirlukast—CYP3A4—Estradiol—prostate cancer	0.00285	0.00605	CbGbCtD
Zafirlukast—CYP3A4—Prednisone—prostate cancer	0.00245	0.0052	CbGbCtD
Zafirlukast—CYSLTR1—prostate gland—prostate cancer	0.00214	0.0997	CbGeAlD
Zafirlukast—CYP2C19—urine—prostate cancer	0.00204	0.0954	CbGeAlD
Zafirlukast—CYP2D6—Doxorubicin—prostate cancer	0.00199	0.00424	CbGbCtD
Zafirlukast—CYP3A4—Etoposide—prostate cancer	0.00186	0.00395	CbGbCtD
Zafirlukast—CYP3A4—Docetaxel—prostate cancer	0.0017	0.00362	CbGbCtD
Zafirlukast—CYP1A2—urine—prostate cancer	0.00167	0.0779	CbGeAlD
Zafirlukast—CYP2C9—urine—prostate cancer	0.00159	0.0739	CbGeAlD
Zafirlukast—CYP2E1—urine—prostate cancer	0.0015	0.0701	CbGeAlD
Zafirlukast—CYP3A4—Doxorubicin—prostate cancer	0.00127	0.00269	CbGbCtD
Zafirlukast—CYP3A4—urine—prostate cancer	0.00121	0.0564	CbGeAlD
Zafirlukast—CYP2D6—urine—prostate cancer	0.00119	0.0555	CbGeAlD
Zafirlukast—CYSLTR1—bone marrow—prostate cancer	0.0011	0.0514	CbGeAlD
Zafirlukast—CYSLTR1—lymph node—prostate cancer	0.000682	0.0318	CbGeAlD
Zafirlukast—ABCG2—prostate gland—prostate cancer	0.000623	0.0291	CbGeAlD
Zafirlukast—CYP2E1—prostate gland—prostate cancer	0.000539	0.0252	CbGeAlD
Zafirlukast—ABCG2—seminal vesicle—prostate cancer	0.000527	0.0246	CbGeAlD
Zafirlukast—PTGS1—prostate gland—prostate cancer	0.00052	0.0242	CbGeAlD
Zafirlukast—CYP2E1—seminal vesicle—prostate cancer	0.000456	0.0213	CbGeAlD
Zafirlukast—PTGS1—seminal vesicle—prostate cancer	0.000439	0.0205	CbGeAlD
Zafirlukast—CYP2C8—renal system—prostate cancer	0.000437	0.0204	CbGeAlD
Zafirlukast—ABCG2—urethra—prostate cancer	0.000417	0.0195	CbGeAlD
Zafirlukast—CYP1A2—renal system—prostate cancer	0.000409	0.0191	CbGeAlD
Zafirlukast—PTGS1—epithelium—prostate cancer	0.000382	0.0178	CbGeAlD
Zafirlukast—CYP2E1—renal system—prostate cancer	0.000368	0.0171	CbGeAlD
Zafirlukast—CYP2E1—urethra—prostate cancer	0.000361	0.0168	CbGeAlD
Zafirlukast—PTGS1—renal system—prostate cancer	0.000354	0.0165	CbGeAlD
Zafirlukast—Tolvaptan—CYP3A4—prostate cancer	0.000325	0.563	CrCbGaD
Zafirlukast—ABCG2—bone marrow—prostate cancer	0.000321	0.015	CbGeAlD
Zafirlukast—CYP3A4—renal system—prostate cancer	0.000296	0.0138	CbGeAlD
Zafirlukast—CYP2D6—renal system—prostate cancer	0.000291	0.0136	CbGeAlD
Zafirlukast—CYP2C8—testis—prostate cancer	0.000282	0.0132	CbGeAlD
Zafirlukast—ABCG2—testis—prostate cancer	0.000274	0.0128	CbGeAlD
Zafirlukast—CYP2E1—testis—prostate cancer	0.000238	0.0111	CbGeAlD
Zafirlukast—PTGS1—testis—prostate cancer	0.000229	0.0107	CbGeAlD
Zafirlukast—ABCG2—lymph node—prostate cancer	0.000199	0.00928	CbGeAlD
Zafirlukast—CYP2D6—testis—prostate cancer	0.000188	0.00878	CbGeAlD
Zafirlukast—PTGS1—lymph node—prostate cancer	0.000166	0.00774	CbGeAlD
Zafirlukast—Glyburide—CYP2C19—prostate cancer	0.000154	0.267	CrCbGaD
Zafirlukast—Glyburide—CYP3A4—prostate cancer	9.79e-05	0.17	CrCbGaD
Zafirlukast—Hypoaesthesia—Docetaxel—prostate cancer	9.58e-05	0.000833	CcSEcCtD
Zafirlukast—Asthenia—Conjugated Estrogens—prostate cancer	9.52e-05	0.000828	CcSEcCtD
Zafirlukast—Pruritus—Goserelin—prostate cancer	9.48e-05	0.000824	CcSEcCtD
Zafirlukast—Pruritus—Conjugated Estrogens—prostate cancer	9.39e-05	0.000816	CcSEcCtD
Zafirlukast—Haemoglobin—Capecitabine—prostate cancer	9.37e-05	0.000815	CcSEcCtD
Zafirlukast—Ill-defined disorder—Etoposide—prostate cancer	9.36e-05	0.000814	CcSEcCtD
Zafirlukast—Dyspepsia—Estradiol—prostate cancer	9.35e-05	0.000813	CcSEcCtD
Zafirlukast—Hepatitis—Capecitabine—prostate cancer	9.32e-05	0.000811	CcSEcCtD
Zafirlukast—Haemorrhage—Capecitabine—prostate cancer	9.32e-05	0.000811	CcSEcCtD
Zafirlukast—Hypoaesthesia—Capecitabine—prostate cancer	9.27e-05	0.000807	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Estradiol—prostate cancer	9.17e-05	0.000797	CcSEcCtD
Zafirlukast—Diarrhoea—Goserelin—prostate cancer	9.17e-05	0.000797	CcSEcCtD
Zafirlukast—Fatigue—Estradiol—prostate cancer	9.16e-05	0.000796	CcSEcCtD
Zafirlukast—Malaise—Etoposide—prostate cancer	9.09e-05	0.000791	CcSEcCtD
Zafirlukast—Dermatitis bullous—Doxorubicin—prostate cancer	9.09e-05	0.00079	CcSEcCtD
Zafirlukast—Pain—Estradiol—prostate cancer	9.08e-05	0.00079	CcSEcCtD
Zafirlukast—Diarrhoea—Conjugated Estrogens—prostate cancer	9.08e-05	0.00079	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Prednisone—prostate cancer	9.07e-05	0.000789	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	9.01e-05	0.000784	CcSEcCtD
Zafirlukast—Dizziness—Goserelin—prostate cancer	8.86e-05	0.00077	CcSEcCtD
Zafirlukast—Dizziness—Conjugated Estrogens—prostate cancer	8.77e-05	0.000763	CcSEcCtD
Zafirlukast—Feeling abnormal—Estradiol—prostate cancer	8.75e-05	0.000761	CcSEcCtD
Zafirlukast—Dyspepsia—Mitoxantrone—prostate cancer	8.71e-05	0.000758	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Estradiol—prostate cancer	8.68e-05	0.000755	CcSEcCtD
Zafirlukast—Liver function test abnormal—Epirubicin—prostate cancer	8.67e-05	0.000754	CcSEcCtD
Zafirlukast—Fatigue—Mitoxantrone—prostate cancer	8.53e-05	0.000742	CcSEcCtD
Zafirlukast—Vomiting—Goserelin—prostate cancer	8.52e-05	0.000741	CcSEcCtD
Zafirlukast—Discomfort—Etoposide—prostate cancer	8.48e-05	0.000738	CcSEcCtD
Zafirlukast—Pain—Mitoxantrone—prostate cancer	8.46e-05	0.000736	CcSEcCtD
Zafirlukast—Rash—Goserelin—prostate cancer	8.45e-05	0.000735	CcSEcCtD
Zafirlukast—Dermatitis—Goserelin—prostate cancer	8.44e-05	0.000734	CcSEcCtD
Zafirlukast—Vomiting—Conjugated Estrogens—prostate cancer	8.44e-05	0.000734	CcSEcCtD
Zafirlukast—Urticaria—Estradiol—prostate cancer	8.44e-05	0.000734	CcSEcCtD
Zafirlukast—Body temperature increased—Estradiol—prostate cancer	8.39e-05	0.00073	CcSEcCtD
Zafirlukast—Abdominal pain—Estradiol—prostate cancer	8.39e-05	0.00073	CcSEcCtD
Zafirlukast—Headache—Goserelin—prostate cancer	8.39e-05	0.00073	CcSEcCtD
Zafirlukast—Rash—Conjugated Estrogens—prostate cancer	8.37e-05	0.000728	CcSEcCtD
Zafirlukast—Dermatitis—Conjugated Estrogens—prostate cancer	8.36e-05	0.000727	CcSEcCtD
Zafirlukast—Haemoglobin—Prednisone—prostate cancer	8.35e-05	0.000726	CcSEcCtD
Zafirlukast—Headache—Conjugated Estrogens—prostate cancer	8.31e-05	0.000723	CcSEcCtD
Zafirlukast—Haemorrhage—Prednisone—prostate cancer	8.3e-05	0.000722	CcSEcCtD
Zafirlukast—Infection—Etoposide—prostate cancer	8.18e-05	0.000711	CcSEcCtD
Zafirlukast—Feeling abnormal—Mitoxantrone—prostate cancer	8.15e-05	0.000709	CcSEcCtD
Zafirlukast—Back pain—Docetaxel—prostate cancer	8.11e-05	0.000705	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Mitoxantrone—prostate cancer	8.09e-05	0.000704	CcSEcCtD
Zafirlukast—Thrombocytopenia—Etoposide—prostate cancer	8.06e-05	0.000701	CcSEcCtD
Zafirlukast—Eosinophilia—Epirubicin—prostate cancer	8.03e-05	0.000699	CcSEcCtD
Zafirlukast—Liver function test abnormal—Doxorubicin—prostate cancer	8.02e-05	0.000697	CcSEcCtD
Zafirlukast—Nausea—Goserelin—prostate cancer	7.96e-05	0.000692	CcSEcCtD
Zafirlukast—Nausea—Conjugated Estrogens—prostate cancer	7.88e-05	0.000685	CcSEcCtD
Zafirlukast—Urticaria—Mitoxantrone—prostate cancer	7.86e-05	0.000684	CcSEcCtD
Zafirlukast—Back pain—Capecitabine—prostate cancer	7.85e-05	0.000683	CcSEcCtD
Zafirlukast—Hypersensitivity—Estradiol—prostate cancer	7.82e-05	0.00068	CcSEcCtD
Zafirlukast—Abdominal pain—Mitoxantrone—prostate cancer	7.82e-05	0.00068	CcSEcCtD
Zafirlukast—Body temperature increased—Mitoxantrone—prostate cancer	7.82e-05	0.00068	CcSEcCtD
Zafirlukast—Asthenia—Estradiol—prostate cancer	7.62e-05	0.000663	CcSEcCtD
Zafirlukast—Neutropenia—Epirubicin—prostate cancer	7.59e-05	0.00066	CcSEcCtD
Zafirlukast—Ill-defined disorder—Capecitabine—prostate cancer	7.53e-05	0.000655	CcSEcCtD
Zafirlukast—Pruritus—Estradiol—prostate cancer	7.51e-05	0.000653	CcSEcCtD
Zafirlukast—Eosinophilia—Doxorubicin—prostate cancer	7.43e-05	0.000646	CcSEcCtD
Zafirlukast—Malaise—Capecitabine—prostate cancer	7.32e-05	0.000636	CcSEcCtD
Zafirlukast—Hypersensitivity—Mitoxantrone—prostate cancer	7.29e-05	0.000634	CcSEcCtD
Zafirlukast—Diarrhoea—Estradiol—prostate cancer	7.27e-05	0.000632	CcSEcCtD
Zafirlukast—Arthralgia—Docetaxel—prostate cancer	7.14e-05	0.000621	CcSEcCtD
Zafirlukast—Myalgia—Docetaxel—prostate cancer	7.14e-05	0.000621	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Etoposide—prostate cancer	7.11e-05	0.000618	CcSEcCtD
Zafirlukast—Asthenia—Mitoxantrone—prostate cancer	7.1e-05	0.000617	CcSEcCtD
Zafirlukast—Fatigue—Etoposide—prostate cancer	7.1e-05	0.000617	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Epirubicin—prostate cancer	7.09e-05	0.000617	CcSEcCtD
Zafirlukast—Jaundice—Epirubicin—prostate cancer	7.05e-05	0.000613	CcSEcCtD
Zafirlukast—Pain—Etoposide—prostate cancer	7.04e-05	0.000612	CcSEcCtD
Zafirlukast—Dizziness—Estradiol—prostate cancer	7.02e-05	0.000611	CcSEcCtD
Zafirlukast—Neutropenia—Doxorubicin—prostate cancer	7.02e-05	0.000611	CcSEcCtD
Zafirlukast—Arthralgia—Capecitabine—prostate cancer	6.91e-05	0.000601	CcSEcCtD
Zafirlukast—Myalgia—Capecitabine—prostate cancer	6.91e-05	0.000601	CcSEcCtD
Zafirlukast—Oedema—Docetaxel—prostate cancer	6.84e-05	0.000595	CcSEcCtD
Zafirlukast—Discomfort—Capecitabine—prostate cancer	6.83e-05	0.000594	CcSEcCtD
Zafirlukast—Infection—Docetaxel—prostate cancer	6.8e-05	0.000591	CcSEcCtD
Zafirlukast—Sinusitis—Epirubicin—prostate cancer	6.79e-05	0.00059	CcSEcCtD
Zafirlukast—Feeling abnormal—Etoposide—prostate cancer	6.78e-05	0.00059	CcSEcCtD
Zafirlukast—Diarrhoea—Mitoxantrone—prostate cancer	6.77e-05	0.000589	CcSEcCtD
Zafirlukast—Vomiting—Estradiol—prostate cancer	6.75e-05	0.000587	CcSEcCtD
Zafirlukast—Agranulocytosis—Epirubicin—prostate cancer	6.75e-05	0.000587	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Etoposide—prostate cancer	6.73e-05	0.000585	CcSEcCtD
Zafirlukast—Ill-defined disorder—Prednisone—prostate cancer	6.71e-05	0.000583	CcSEcCtD
Zafirlukast—Thrombocytopenia—Docetaxel—prostate cancer	6.7e-05	0.000582	CcSEcCtD
Zafirlukast—Rash—Estradiol—prostate cancer	6.7e-05	0.000582	CcSEcCtD
Zafirlukast—Dermatitis—Estradiol—prostate cancer	6.69e-05	0.000582	CcSEcCtD
Zafirlukast—Headache—Estradiol—prostate cancer	6.65e-05	0.000579	CcSEcCtD
Zafirlukast—Oedema—Capecitabine—prostate cancer	6.62e-05	0.000576	CcSEcCtD
Zafirlukast—Angioedema—Prednisone—prostate cancer	6.6e-05	0.000574	CcSEcCtD
Zafirlukast—Infection—Capecitabine—prostate cancer	6.58e-05	0.000572	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Doxorubicin—prostate cancer	6.56e-05	0.000571	CcSEcCtD
Zafirlukast—Urticaria—Etoposide—prostate cancer	6.54e-05	0.000569	CcSEcCtD
Zafirlukast—Haemoglobin—Epirubicin—prostate cancer	6.53e-05	0.000568	CcSEcCtD
Zafirlukast—Jaundice—Doxorubicin—prostate cancer	6.52e-05	0.000567	CcSEcCtD
Zafirlukast—Malaise—Prednisone—prostate cancer	6.52e-05	0.000567	CcSEcCtD
Zafirlukast—Abdominal pain—Etoposide—prostate cancer	6.51e-05	0.000566	CcSEcCtD
Zafirlukast—Body temperature increased—Etoposide—prostate cancer	6.51e-05	0.000566	CcSEcCtD
Zafirlukast—Haemorrhage—Epirubicin—prostate cancer	6.49e-05	0.000565	CcSEcCtD
Zafirlukast—Hepatitis—Epirubicin—prostate cancer	6.49e-05	0.000565	CcSEcCtD
Zafirlukast—Thrombocytopenia—Capecitabine—prostate cancer	6.48e-05	0.000564	CcSEcCtD
Zafirlukast—Hypoaesthesia—Epirubicin—prostate cancer	6.46e-05	0.000562	CcSEcCtD
Zafirlukast—Nausea—Estradiol—prostate cancer	6.31e-05	0.000549	CcSEcCtD
Zafirlukast—Vomiting—Mitoxantrone—prostate cancer	6.29e-05	0.000547	CcSEcCtD
Zafirlukast—Sinusitis—Doxorubicin—prostate cancer	6.28e-05	0.000546	CcSEcCtD
Zafirlukast—Agranulocytosis—Doxorubicin—prostate cancer	6.25e-05	0.000543	CcSEcCtD
Zafirlukast—Rash—Mitoxantrone—prostate cancer	6.24e-05	0.000543	CcSEcCtD
Zafirlukast—Dermatitis—Mitoxantrone—prostate cancer	6.23e-05	0.000542	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Docetaxel—prostate cancer	6.23e-05	0.000542	CcSEcCtD
Zafirlukast—Headache—Mitoxantrone—prostate cancer	6.2e-05	0.000539	CcSEcCtD
Zafirlukast—Insomnia—Docetaxel—prostate cancer	6.19e-05	0.000538	CcSEcCtD
Zafirlukast—Arthralgia—Prednisone—prostate cancer	6.15e-05	0.000535	CcSEcCtD
Zafirlukast—Myalgia—Prednisone—prostate cancer	6.15e-05	0.000535	CcSEcCtD
Zafirlukast—Discomfort—Prednisone—prostate cancer	6.08e-05	0.000529	CcSEcCtD
Zafirlukast—Hypersensitivity—Etoposide—prostate cancer	6.06e-05	0.000527	CcSEcCtD
Zafirlukast—Haemoglobin—Doxorubicin—prostate cancer	6.04e-05	0.000525	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Capecitabine—prostate cancer	6.03e-05	0.000525	CcSEcCtD
Zafirlukast—Dyspepsia—Docetaxel—prostate cancer	6.02e-05	0.000524	CcSEcCtD
Zafirlukast—Haemorrhage—Doxorubicin—prostate cancer	6.01e-05	0.000523	CcSEcCtD
Zafirlukast—Hepatitis—Doxorubicin—prostate cancer	6.01e-05	0.000523	CcSEcCtD
Zafirlukast—Insomnia—Capecitabine—prostate cancer	5.99e-05	0.000521	CcSEcCtD
Zafirlukast—Hypoaesthesia—Doxorubicin—prostate cancer	5.98e-05	0.00052	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Docetaxel—prostate cancer	5.91e-05	0.000514	CcSEcCtD
Zafirlukast—Asthenia—Etoposide—prostate cancer	5.91e-05	0.000514	CcSEcCtD
Zafirlukast—Oedema—Prednisone—prostate cancer	5.9e-05	0.000513	CcSEcCtD
Zafirlukast—Fatigue—Docetaxel—prostate cancer	5.9e-05	0.000513	CcSEcCtD
Zafirlukast—Nausea—Mitoxantrone—prostate cancer	5.88e-05	0.000511	CcSEcCtD
Zafirlukast—Infection—Prednisone—prostate cancer	5.86e-05	0.00051	CcSEcCtD
Zafirlukast—Pain—Docetaxel—prostate cancer	5.85e-05	0.000509	CcSEcCtD
Zafirlukast—Dyspepsia—Capecitabine—prostate cancer	5.83e-05	0.000507	CcSEcCtD
Zafirlukast—Pruritus—Etoposide—prostate cancer	5.82e-05	0.000506	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Capecitabine—prostate cancer	5.72e-05	0.000497	CcSEcCtD
Zafirlukast—Fatigue—Capecitabine—prostate cancer	5.71e-05	0.000497	CcSEcCtD
Zafirlukast—Pain—Capecitabine—prostate cancer	5.66e-05	0.000493	CcSEcCtD
Zafirlukast—Feeling abnormal—Docetaxel—prostate cancer	5.64e-05	0.00049	CcSEcCtD
Zafirlukast—Diarrhoea—Etoposide—prostate cancer	5.63e-05	0.00049	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Docetaxel—prostate cancer	5.59e-05	0.000486	CcSEcCtD
Zafirlukast—Back pain—Epirubicin—prostate cancer	5.47e-05	0.000476	CcSEcCtD
Zafirlukast—Feeling abnormal—Capecitabine—prostate cancer	5.46e-05	0.000475	CcSEcCtD
Zafirlukast—Dizziness—Etoposide—prostate cancer	5.44e-05	0.000473	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Capecitabine—prostate cancer	5.42e-05	0.000471	CcSEcCtD
Zafirlukast—Abdominal pain—Docetaxel—prostate cancer	5.41e-05	0.00047	CcSEcCtD
Zafirlukast—Body temperature increased—Docetaxel—prostate cancer	5.41e-05	0.00047	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Prednisone—prostate cancer	5.37e-05	0.000467	CcSEcCtD
Zafirlukast—Insomnia—Prednisone—prostate cancer	5.34e-05	0.000464	CcSEcCtD
Zafirlukast—Urticaria—Capecitabine—prostate cancer	5.26e-05	0.000458	CcSEcCtD
Zafirlukast—Ill-defined disorder—Epirubicin—prostate cancer	5.25e-05	0.000456	CcSEcCtD
Zafirlukast—Abdominal pain—Capecitabine—prostate cancer	5.24e-05	0.000455	CcSEcCtD
Zafirlukast—Body temperature increased—Capecitabine—prostate cancer	5.24e-05	0.000455	CcSEcCtD
Zafirlukast—Vomiting—Etoposide—prostate cancer	5.23e-05	0.000455	CcSEcCtD
Zafirlukast—Dyspepsia—Prednisone—prostate cancer	5.19e-05	0.000452	CcSEcCtD
Zafirlukast—Rash—Etoposide—prostate cancer	5.19e-05	0.000451	CcSEcCtD
Zafirlukast—Dermatitis—Etoposide—prostate cancer	5.18e-05	0.000451	CcSEcCtD
Zafirlukast—Headache—Etoposide—prostate cancer	5.16e-05	0.000448	CcSEcCtD
Zafirlukast—Malaise—Epirubicin—prostate cancer	5.1e-05	0.000443	CcSEcCtD
Zafirlukast—Fatigue—Prednisone—prostate cancer	5.09e-05	0.000442	CcSEcCtD
Zafirlukast—Back pain—Doxorubicin—prostate cancer	5.06e-05	0.00044	CcSEcCtD
Zafirlukast—Hypersensitivity—Docetaxel—prostate cancer	5.04e-05	0.000438	CcSEcCtD
Zafirlukast—Asthenia—Docetaxel—prostate cancer	4.91e-05	0.000427	CcSEcCtD
Zafirlukast—Nausea—Etoposide—prostate cancer	4.89e-05	0.000425	CcSEcCtD
Zafirlukast—Hypersensitivity—Capecitabine—prostate cancer	4.88e-05	0.000424	CcSEcCtD
Zafirlukast—Feeling abnormal—Prednisone—prostate cancer	4.86e-05	0.000423	CcSEcCtD
Zafirlukast—Ill-defined disorder—Doxorubicin—prostate cancer	4.85e-05	0.000422	CcSEcCtD
Zafirlukast—Pruritus—Docetaxel—prostate cancer	4.84e-05	0.000421	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Prednisone—prostate cancer	4.82e-05	0.00042	CcSEcCtD
Zafirlukast—Myalgia—Epirubicin—prostate cancer	4.81e-05	0.000419	CcSEcCtD
Zafirlukast—Arthralgia—Epirubicin—prostate cancer	4.81e-05	0.000419	CcSEcCtD
Zafirlukast—Discomfort—Epirubicin—prostate cancer	4.75e-05	0.000414	CcSEcCtD
Zafirlukast—Asthenia—Capecitabine—prostate cancer	4.75e-05	0.000413	CcSEcCtD
Zafirlukast—Malaise—Doxorubicin—prostate cancer	4.72e-05	0.00041	CcSEcCtD
Zafirlukast—Urticaria—Prednisone—prostate cancer	4.69e-05	0.000408	CcSEcCtD
Zafirlukast—Pruritus—Capecitabine—prostate cancer	4.69e-05	0.000408	CcSEcCtD
Zafirlukast—Diarrhoea—Docetaxel—prostate cancer	4.68e-05	0.000407	CcSEcCtD
Zafirlukast—Abdominal pain—Prednisone—prostate cancer	4.66e-05	0.000406	CcSEcCtD
Zafirlukast—Body temperature increased—Prednisone—prostate cancer	4.66e-05	0.000406	CcSEcCtD
Zafirlukast—Oedema—Epirubicin—prostate cancer	4.61e-05	0.000401	CcSEcCtD
Zafirlukast—Infection—Epirubicin—prostate cancer	4.58e-05	0.000399	CcSEcCtD
Zafirlukast—Diarrhoea—Capecitabine—prostate cancer	4.53e-05	0.000394	CcSEcCtD
Zafirlukast—Dizziness—Docetaxel—prostate cancer	4.52e-05	0.000393	CcSEcCtD
Zafirlukast—Thrombocytopenia—Epirubicin—prostate cancer	4.52e-05	0.000393	CcSEcCtD
Zafirlukast—Arthralgia—Doxorubicin—prostate cancer	4.45e-05	0.000387	CcSEcCtD
Zafirlukast—Myalgia—Doxorubicin—prostate cancer	4.45e-05	0.000387	CcSEcCtD
Zafirlukast—Discomfort—Doxorubicin—prostate cancer	4.4e-05	0.000383	CcSEcCtD
Zafirlukast—Dizziness—Capecitabine—prostate cancer	4.38e-05	0.000381	CcSEcCtD
Zafirlukast—Vomiting—Docetaxel—prostate cancer	4.35e-05	0.000378	CcSEcCtD
Zafirlukast—Hypersensitivity—Prednisone—prostate cancer	4.35e-05	0.000378	CcSEcCtD
Zafirlukast—Rash—Docetaxel—prostate cancer	4.31e-05	0.000375	CcSEcCtD
Zafirlukast—Dermatitis—Docetaxel—prostate cancer	4.31e-05	0.000375	CcSEcCtD
Zafirlukast—Headache—Docetaxel—prostate cancer	4.29e-05	0.000373	CcSEcCtD
Zafirlukast—Oedema—Doxorubicin—prostate cancer	4.27e-05	0.000371	CcSEcCtD
Zafirlukast—Infection—Doxorubicin—prostate cancer	4.24e-05	0.000369	CcSEcCtD
Zafirlukast—Asthenia—Prednisone—prostate cancer	4.23e-05	0.000368	CcSEcCtD
Zafirlukast—Vomiting—Capecitabine—prostate cancer	4.21e-05	0.000366	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Epirubicin—prostate cancer	4.2e-05	0.000366	CcSEcCtD
Zafirlukast—Thrombocytopenia—Doxorubicin—prostate cancer	4.18e-05	0.000364	CcSEcCtD
Zafirlukast—Rash—Capecitabine—prostate cancer	4.18e-05	0.000363	CcSEcCtD
Zafirlukast—Pruritus—Prednisone—prostate cancer	4.17e-05	0.000363	CcSEcCtD
Zafirlukast—Insomnia—Epirubicin—prostate cancer	4.17e-05	0.000363	CcSEcCtD
Zafirlukast—Dermatitis—Capecitabine—prostate cancer	4.17e-05	0.000363	CcSEcCtD
Zafirlukast—Headache—Capecitabine—prostate cancer	4.15e-05	0.000361	CcSEcCtD
Zafirlukast—Nausea—Docetaxel—prostate cancer	4.06e-05	0.000353	CcSEcCtD
Zafirlukast—Dyspepsia—Epirubicin—prostate cancer	4.06e-05	0.000353	CcSEcCtD
Zafirlukast—Diarrhoea—Prednisone—prostate cancer	4.04e-05	0.000351	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Epirubicin—prostate cancer	3.98e-05	0.000346	CcSEcCtD
Zafirlukast—Fatigue—Epirubicin—prostate cancer	3.98e-05	0.000346	CcSEcCtD
Zafirlukast—Pain—Epirubicin—prostate cancer	3.95e-05	0.000343	CcSEcCtD
Zafirlukast—Nausea—Capecitabine—prostate cancer	3.93e-05	0.000342	CcSEcCtD
Zafirlukast—Dizziness—Prednisone—prostate cancer	3.9e-05	0.000339	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.89e-05	0.000338	CcSEcCtD
Zafirlukast—Insomnia—Doxorubicin—prostate cancer	3.86e-05	0.000336	CcSEcCtD
Zafirlukast—Feeling abnormal—Epirubicin—prostate cancer	3.8e-05	0.000331	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Epirubicin—prostate cancer	3.77e-05	0.000328	CcSEcCtD
Zafirlukast—Dyspepsia—Doxorubicin—prostate cancer	3.76e-05	0.000327	CcSEcCtD
Zafirlukast—Vomiting—Prednisone—prostate cancer	3.75e-05	0.000326	CcSEcCtD
Zafirlukast—Rash—Prednisone—prostate cancer	3.72e-05	0.000323	CcSEcCtD
Zafirlukast—Dermatitis—Prednisone—prostate cancer	3.72e-05	0.000323	CcSEcCtD
Zafirlukast—Headache—Prednisone—prostate cancer	3.7e-05	0.000321	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.69e-05	0.000321	CcSEcCtD
Zafirlukast—Fatigue—Doxorubicin—prostate cancer	3.68e-05	0.00032	CcSEcCtD
Zafirlukast—Urticaria—Epirubicin—prostate cancer	3.67e-05	0.000319	CcSEcCtD
Zafirlukast—Pain—Doxorubicin—prostate cancer	3.65e-05	0.000317	CcSEcCtD
Zafirlukast—Body temperature increased—Epirubicin—prostate cancer	3.65e-05	0.000317	CcSEcCtD
Zafirlukast—Abdominal pain—Epirubicin—prostate cancer	3.65e-05	0.000317	CcSEcCtD
Zafirlukast—Feeling abnormal—Doxorubicin—prostate cancer	3.52e-05	0.000306	CcSEcCtD
Zafirlukast—Nausea—Prednisone—prostate cancer	3.5e-05	0.000305	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Doxorubicin—prostate cancer	3.49e-05	0.000304	CcSEcCtD
Zafirlukast—Hypersensitivity—Epirubicin—prostate cancer	3.4e-05	0.000296	CcSEcCtD
Zafirlukast—Urticaria—Doxorubicin—prostate cancer	3.39e-05	0.000295	CcSEcCtD
Zafirlukast—Abdominal pain—Doxorubicin—prostate cancer	3.37e-05	0.000294	CcSEcCtD
Zafirlukast—Body temperature increased—Doxorubicin—prostate cancer	3.37e-05	0.000294	CcSEcCtD
Zafirlukast—Asthenia—Epirubicin—prostate cancer	3.31e-05	0.000288	CcSEcCtD
Zafirlukast—Pruritus—Epirubicin—prostate cancer	3.26e-05	0.000284	CcSEcCtD
Zafirlukast—Diarrhoea—Epirubicin—prostate cancer	3.16e-05	0.000275	CcSEcCtD
Zafirlukast—Hypersensitivity—Doxorubicin—prostate cancer	3.15e-05	0.000274	CcSEcCtD
Zafirlukast—Asthenia—Doxorubicin—prostate cancer	3.06e-05	0.000266	CcSEcCtD
Zafirlukast—Dizziness—Epirubicin—prostate cancer	3.05e-05	0.000265	CcSEcCtD
Zafirlukast—Pruritus—Doxorubicin—prostate cancer	3.02e-05	0.000263	CcSEcCtD
Zafirlukast—Vomiting—Epirubicin—prostate cancer	2.93e-05	0.000255	CcSEcCtD
Zafirlukast—Diarrhoea—Doxorubicin—prostate cancer	2.92e-05	0.000254	CcSEcCtD
Zafirlukast—Rash—Epirubicin—prostate cancer	2.91e-05	0.000253	CcSEcCtD
Zafirlukast—Dermatitis—Epirubicin—prostate cancer	2.91e-05	0.000253	CcSEcCtD
Zafirlukast—Headache—Epirubicin—prostate cancer	2.89e-05	0.000251	CcSEcCtD
Zafirlukast—Dizziness—Doxorubicin—prostate cancer	2.82e-05	0.000246	CcSEcCtD
Zafirlukast—Nausea—Epirubicin—prostate cancer	2.74e-05	0.000238	CcSEcCtD
Zafirlukast—Vomiting—Doxorubicin—prostate cancer	2.71e-05	0.000236	CcSEcCtD
Zafirlukast—Rash—Doxorubicin—prostate cancer	2.69e-05	0.000234	CcSEcCtD
Zafirlukast—Dermatitis—Doxorubicin—prostate cancer	2.69e-05	0.000234	CcSEcCtD
Zafirlukast—Headache—Doxorubicin—prostate cancer	2.67e-05	0.000233	CcSEcCtD
Zafirlukast—Nausea—Doxorubicin—prostate cancer	2.54e-05	0.000221	CcSEcCtD
Zafirlukast—CYP1A2—Metabolism—GSTT1—prostate cancer	2.39e-06	2.37e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AKT1—prostate cancer	2.39e-06	2.37e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTP1—prostate cancer	2.38e-06	2.36e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—INS—prostate cancer	2.38e-06	2.36e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ERCC2—prostate cancer	2.38e-06	2.36e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.37e-06	2.36e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTO1—prostate cancer	2.37e-06	2.36e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NAT2—prostate cancer	2.37e-06	2.36e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP2E1—prostate cancer	2.37e-06	2.35e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GGT1—prostate cancer	2.36e-06	2.34e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP2A6—prostate cancer	2.36e-06	2.34e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.35e-06	2.33e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.35e-06	2.33e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NQO1—prostate cancer	2.34e-06	2.32e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ITPR1—prostate cancer	2.34e-06	2.32e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CREBBP—prostate cancer	2.33e-06	2.31e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NCOA1—prostate cancer	2.33e-06	2.31e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NQO1—prostate cancer	2.32e-06	2.3e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TH—prostate cancer	2.31e-06	2.29e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.3e-06	2.28e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CD—prostate cancer	2.3e-06	2.28e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKR1C3—prostate cancer	2.29e-06	2.28e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP19A1—prostate cancer	2.29e-06	2.28e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TH—prostate cancer	2.29e-06	2.27e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.28e-06	2.26e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PRKACB—prostate cancer	2.28e-06	2.26e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PLCB2—prostate cancer	2.28e-06	2.26e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.28e-06	2.26e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—LRP2—prostate cancer	2.28e-06	2.26e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.27e-06	2.25e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.26e-06	2.24e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP17A1—prostate cancer	2.26e-06	2.24e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.25e-06	2.23e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.24e-06	2.23e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—MTHFR—prostate cancer	2.23e-06	2.22e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—P4HB—prostate cancer	2.23e-06	2.21e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.23e-06	2.21e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.22e-06	2.21e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—RXRA—prostate cancer	2.21e-06	2.2e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TYMS—prostate cancer	2.21e-06	2.19e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CD—prostate cancer	2.21e-06	2.19e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PPARA—prostate cancer	2.19e-06	2.17e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTM1—prostate cancer	2.19e-06	2.17e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GGT1—prostate cancer	2.17e-06	2.16e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.17e-06	2.15e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—NOS3—prostate cancer	2.17e-06	2.15e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GGT1—prostate cancer	2.15e-06	2.14e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.15e-06	2.14e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NCOA2—prostate cancer	2.15e-06	2.13e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—LPL—prostate cancer	2.15e-06	2.13e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NCOA1—prostate cancer	2.14e-06	2.12e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—COMT—prostate cancer	2.13e-06	2.12e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTP1—prostate cancer	2.12e-06	2.11e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NCOA1—prostate cancer	2.12e-06	2.1e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.12e-06	2.1e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.11e-06	2.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.09e-06	2.07e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ITPR1—prostate cancer	2.09e-06	2.07e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—NOS3—prostate cancer	2.09e-06	2.07e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MED12—prostate cancer	2.08e-06	2.07e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP1A1—prostate cancer	2.07e-06	2.05e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GNG5—prostate cancer	2.07e-06	2.05e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CAV1—prostate cancer	2.06e-06	2.04e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ERCC2—prostate cancer	2.05e-06	2.04e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.05e-06	2.04e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.05e-06	2.04e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—RXRA—prostate cancer	2.04e-06	2.02e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—RXRA—prostate cancer	2.02e-06	2e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.01e-06	1.99e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CB—prostate cancer	2e-06	1.99e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NCOA3—prostate cancer	1.99e-06	1.97e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTGS2—prostate cancer	1.99e-06	1.97e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NQO1—prostate cancer	1.98e-06	1.97e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TYMS—prostate cancer	1.97e-06	1.96e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.96e-06	1.95e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—COMT—prostate cancer	1.96e-06	1.95e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TH—prostate cancer	1.95e-06	1.94e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTP1—prostate cancer	1.95e-06	1.94e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTM1—prostate cancer	1.95e-06	1.93e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—COMT—prostate cancer	1.94e-06	1.93e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.94e-06	1.93e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTP1—prostate cancer	1.94e-06	1.92e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.93e-06	1.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—MTHFR—prostate cancer	1.93e-06	1.92e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CB—prostate cancer	1.92e-06	1.91e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.92e-06	1.91e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ITPR1—prostate cancer	1.92e-06	1.91e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—LPL—prostate cancer	1.91e-06	1.9e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTGS2—prostate cancer	1.91e-06	1.89e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ITPR1—prostate cancer	1.9e-06	1.89e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.9e-06	1.89e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HPGDS—prostate cancer	1.9e-06	1.88e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPARA—prostate cancer	1.89e-06	1.88e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.89e-06	1.87e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CG—prostate cancer	1.88e-06	1.86e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.87e-06	1.86e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.85e-06	1.83e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTT1—prostate cancer	1.84e-06	1.83e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ACHE—prostate cancer	1.84e-06	1.83e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GGT1—prostate cancer	1.84e-06	1.83e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ERCC2—prostate cancer	1.83e-06	1.82e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.82e-06	1.81e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TYMS—prostate cancer	1.82e-06	1.8e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NCOA1—prostate cancer	1.81e-06	1.8e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TYMS—prostate cancer	1.8e-06	1.78e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTM1—prostate cancer	1.79e-06	1.78e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.79e-06	1.77e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CAV1—prostate cancer	1.78e-06	1.77e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTM1—prostate cancer	1.78e-06	1.76e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—INS—prostate cancer	1.78e-06	1.76e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.77e-06	1.76e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PRKACB—prostate cancer	1.76e-06	1.75e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—LPL—prostate cancer	1.76e-06	1.75e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—LPL—prostate cancer	1.75e-06	1.73e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.74e-06	1.73e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CREBBP—prostate cancer	1.74e-06	1.73e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTEN—prostate cancer	1.73e-06	1.72e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—RXRA—prostate cancer	1.73e-06	1.71e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—MTHFR—prostate cancer	1.72e-06	1.71e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.7e-06	1.69e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.7e-06	1.69e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPARA—prostate cancer	1.69e-06	1.68e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ERCC2—prostate cancer	1.69e-06	1.67e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.69e-06	1.67e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.68e-06	1.66e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ERCC2—prostate cancer	1.67e-06	1.66e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTEN—prostate cancer	1.66e-06	1.65e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—COMT—prostate cancer	1.66e-06	1.65e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NCOA2—prostate cancer	1.66e-06	1.65e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTP1—prostate cancer	1.65e-06	1.64e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—EP300—prostate cancer	1.65e-06	1.64e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CD—prostate cancer	1.65e-06	1.64e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ITPR1—prostate cancer	1.63e-06	1.61e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.62e-06	1.61e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.6e-06	1.59e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CAV1—prostate cancer	1.59e-06	1.58e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—EP300—prostate cancer	1.59e-06	1.57e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—MTHFR—prostate cancer	1.59e-06	1.57e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.58e-06	1.57e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—MTHFR—prostate cancer	1.57e-06	1.56e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—NOS3—prostate cancer	1.56e-06	1.55e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPARA—prostate cancer	1.56e-06	1.54e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.55e-06	1.53e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPARA—prostate cancer	1.54e-06	1.53e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TYMS—prostate cancer	1.54e-06	1.52e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—INS—prostate cancer	1.54e-06	1.52e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NQO1—prostate cancer	1.53e-06	1.52e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTM1—prostate cancer	1.52e-06	1.51e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.52e-06	1.51e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TH—prostate cancer	1.51e-06	1.5e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CREBBP—prostate cancer	1.5e-06	1.49e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—LPL—prostate cancer	1.49e-06	1.48e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.47e-06	1.46e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CAV1—prostate cancer	1.46e-06	1.45e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CAV1—prostate cancer	1.45e-06	1.44e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.45e-06	1.44e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.44e-06	1.43e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.44e-06	1.43e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ERCC2—prostate cancer	1.43e-06	1.42e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.43e-06	1.41e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS2—prostate cancer	1.43e-06	1.41e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GGT1—prostate cancer	1.42e-06	1.41e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NCOA1—prostate cancer	1.4e-06	1.39e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.39e-06	1.37e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.38e-06	1.37e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—INS—prostate cancer	1.37e-06	1.36e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—NOS3—prostate cancer	1.35e-06	1.34e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—MTHFR—prostate cancer	1.34e-06	1.33e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CREBBP—prostate cancer	1.34e-06	1.33e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.33e-06	1.32e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—RXRA—prostate cancer	1.33e-06	1.32e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.32e-06	1.31e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPARA—prostate cancer	1.32e-06	1.31e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—COMT—prostate cancer	1.28e-06	1.27e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTP1—prostate cancer	1.28e-06	1.27e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.27e-06	1.26e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—INS—prostate cancer	1.26e-06	1.25e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ITPR1—prostate cancer	1.26e-06	1.25e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—INS—prostate cancer	1.25e-06	1.24e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.24e-06	1.23e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTEN—prostate cancer	1.24e-06	1.23e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CAV1—prostate cancer	1.24e-06	1.23e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CREBBP—prostate cancer	1.24e-06	1.22e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS2—prostate cancer	1.23e-06	1.22e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CREBBP—prostate cancer	1.22e-06	1.21e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CA—prostate cancer	1.22e-06	1.21e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NOS3—prostate cancer	1.2e-06	1.19e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TYMS—prostate cancer	1.19e-06	1.18e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—EP300—prostate cancer	1.19e-06	1.18e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.18e-06	1.17e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CA—prostate cancer	1.17e-06	1.16e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTM1—prostate cancer	1.17e-06	1.16e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.17e-06	1.16e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.16e-06	1.15e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—LPL—prostate cancer	1.15e-06	1.14e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.13e-06	1.12e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.11e-06	1.1e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.11e-06	1.1e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NOS3—prostate cancer	1.11e-06	1.1e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ERCC2—prostate cancer	1.1e-06	1.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS2—prostate cancer	1.1e-06	1.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NOS3—prostate cancer	1.1e-06	1.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTEN—prostate cancer	1.07e-06	1.07e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—INS—prostate cancer	1.07e-06	1.06e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CREBBP—prostate cancer	1.05e-06	1.04e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MTHFR—prostate cancer	1.04e-06	1.03e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—EP300—prostate cancer	1.02e-06	1.02e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.02e-06	1.01e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPARA—prostate cancer	1.02e-06	1.01e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.01e-06	1e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS2—prostate cancer	1.01e-06	1e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS2—prostate cancer	1e-06	9.94e-06	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKT1—prostate cancer	9.98e-07	9.9e-06	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CD—prostate cancer	9.92e-07	9.84e-06	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTEN—prostate cancer	9.59e-07	9.51e-06	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKT1—prostate cancer	9.59e-07	9.51e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CAV1—prostate cancer	9.56e-07	9.48e-06	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NOS3—prostate cancer	9.37e-07	9.29e-06	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—EP300—prostate cancer	9.15e-07	9.07e-06	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTEN—prostate cancer	8.82e-07	8.75e-06	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CA—prostate cancer	8.77e-07	8.7e-06	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTEN—prostate cancer	8.74e-07	8.67e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CG—prostate cancer	8.71e-07	8.64e-06	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CB—prostate cancer	8.65e-07	8.58e-06	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS2—prostate cancer	8.57e-07	8.5e-06	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—EP300—prostate cancer	8.41e-07	8.34e-06	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—EP300—prostate cancer	8.34e-07	8.27e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—INS—prostate cancer	8.24e-07	8.18e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CREBBP—prostate cancer	8.08e-07	8.01e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CD—prostate cancer	7.66e-07	7.59e-06	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CA—prostate cancer	7.58e-07	7.52e-06	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTEN—prostate cancer	7.47e-07	7.41e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NOS3—prostate cancer	7.23e-07	7.17e-06	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKT1—prostate cancer	7.16e-07	7.1e-06	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—EP300—prostate cancer	7.13e-07	7.07e-06	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CA—prostate cancer	6.77e-07	6.71e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CB—prostate cancer	6.67e-07	6.62e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS2—prostate cancer	6.61e-07	6.56e-06	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CA—prostate cancer	6.22e-07	6.17e-06	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKT1—prostate cancer	6.19e-07	6.14e-06	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CA—prostate cancer	6.17e-07	6.12e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTEN—prostate cancer	5.77e-07	5.72e-06	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKT1—prostate cancer	5.53e-07	5.48e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—EP300—prostate cancer	5.5e-07	5.45e-06	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CA—prostate cancer	5.27e-07	5.23e-06	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKT1—prostate cancer	5.08e-07	5.04e-06	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKT1—prostate cancer	5.04e-07	5e-06	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKT1—prostate cancer	4.31e-07	4.27e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.07e-07	4.03e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKT1—prostate cancer	3.32e-07	3.3e-06	CbGpPWpGaD
